Nightspire Claims Ransomware Attack on Forma Therapeutics
Summary
Nightspire claims it targeted Forma Therapeutics and obtained clinical, research, drug-discovery, and biological data. The monitoring post says the claims are unverified.
Key points
- The monitoring post attributes the claim to the Nightspire ransomware group.
- The alleged affected information includes clinical trial and statistical data, electronic lab notebooks, research IP, drug-discovery and pipeline data, and biological and genomic data.
- The post says it is based on public claims by the ransomware group and that the information could not be confirmed.
Article Details
- Victim
- Forma Therapeutics Holdings, Inc.
- Claim Date
- 2026-09-21
- Encryption Status
- Unknown; the source does not report whether data was encrypted.
- Exfiltration Status
- Unconfirmed; the source reports a public ransomware-group claim but says it cannot confirm the information.
- Exfiltrated Data
- The claim lists clinical trial and statistical data, electronic lab notebooks and research IP, drug discovery and pipeline data, and biological research and genomic data.
- Leak Status
- A claim was published; the source does not confirm that data was leaked or published.